ketoconazole has been researched along with Recrudescence in 109 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate efficacy and cost of using cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs." | 9.10 | Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs. ( Hardie, RJ; McAnulty, JE; Patricelli, AJ, 2002) |
| "To assess the efficacy and safety of itraconazole in preventing relapse of histoplasmosis after induction therapy with amphotericin B in patients with the acquired immunodeficiency syndrome (AIDS) and disseminated histoplasmosis." | 9.07 | Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. ( Briggs, N; Connolly-Stringfield, P; Hafner, R; Hamill, R; Murphy, R; Owens, S; Powderly, W; Rinaldi, M; Saag, M; Spencer, P; Squires, K; Wheat, J; Wong, B; Wulfsohn, M, 1993) |
| "Itraconazole, 200 to 400 mg once daily, was administered to 49 patients with different types of aspergillosis: pulmonary aspergilloma (14 patients), chronic necrotizing pulmonary aspergillosis (14), and invasive aspergillosis (21)." | 9.06 | Itraconazole therapy in aspergillosis: study in 49 patients. ( Dupont, B, 1990) |
| " One patient had 2 recurrent ischemic priapism episodes while on ketoconazole and prednisone treatment." | 7.75 | Ketoconazole and prednisone to prevent recurrent ischemic priapism. ( Abern, MR; Levine, LA, 2009) |
| "Itraconazole, a new oral triazole antifungal agent, was administered in 75 courses to patients with chronic coccidioidomycosis at dosages of 50 to 400 mg/day for a median duration of 10 months." | 7.68 | Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations. ( Arathoon, EG; Denning, DW; Rinaldi, MG; Stevens, DA; Tucker, RM, 1990) |
| "The purpose of this study was to assess the tolerance and efficacy of itraconazole in the treatment of coccidioidomycosis." | 7.68 | Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group. ( Cloud, GA; Dismukes, WE; Galgiani, JN; Graybill, JR; Stevens, DA, 1990) |
| "Sixteen patients with coccidioidomycosis were treated with itraconazole for one year." | 7.68 | Itraconazole in the treatment of coccidioidomycosis. ( Cruz, S; de Hoyos, LA; Diaz, M; Puente, R, 1991) |
| "Ketoconazole appears to be a safe drug in the treatment of chronic cavitary histoplasmosis." | 7.67 | Chronic cavitary histoplasmosis. Failure of oral treatment with ketoconazole. ( Gorin, AB; Hamill, RJ; Musher, DM; Quinones, CA; Reuben, AG; Sarosi, GA, 1989) |
| "We report a patient with pulmonary blastomycosis who suffered relapse with dissemination of her disease after five months of apparent response to therapy with ketoconazole, 400 mg daily." | 7.67 | Late dissemination of pulmonary blastomycosis during ketoconazole therapy. ( George, RB; Hebert, CA; King, JW, 1989) |
| "Forty-seven courses of oral ketoconazole therapy administered to 46 patients with progressive coccidioidomycosis were evaluated." | 7.66 | Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis. ( Stevens, DA; Stiller, RL; Sugar, AM; Williams, PL, 1983) |
| "Favus is common in Iran, Nigeria, and China, however it has been reported rarely in the last two decades in Turkey." | 5.42 | [A recurrent case of adult favus successfully treated with terbinafine]. ( Acar, A; Erkan, D; İlkit, M; Kandemir, H; Kolukırık, İ, 2015) |
| " We compared our previous protocol of three times daily (TID) KTZ dosing with prednisone for 6 months with our current regimen of initiating KTZ 200 mg TID with prednisone 5 mg daily for 2 weeks and then tapering to KTZ 200 mg nightly for 6 months." | 5.40 | Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes. ( Hoeh, MP; Levine, LA, 2014) |
| "A case of mycetoma of the lower leg (Madura foot) with bone involvement caused by Petriellidium boydii is presented." | 5.27 | [Mycetoma caused by Petriellidium boydii: treatment with ketoconazole]. ( Auböck, J; Fritsch, P; Pichler, E, 1985) |
| " Review of these five cases and 31 additional relapsing cases from the literature indicates that fungal endocarditis or endarteritis without surgical treatment, underlying lymphoreticular neoplasm, and amphotericin B dosage of less than 2 g appear to be associated with relapse of PDH." | 5.26 | Conditions associated with relapse of amphotericin B-treated disseminated histoplasmosis. ( Alford, RH; Bradsher, RW; Hawkins, SS; Spickard, WA, 1982) |
| "Ketoconazole 2% foam was evaluated in a single-center, open-label, one-arm pilot study which enrolled eleven subjects to gain 10 evaluable subjects aged 21 years and older with a clinical diagnosis of tinea versicolor and positive KOH using calcofluor." | 5.19 | Can pityriasis versicolor be treated with 2% ketoconazole foam? ( Cantrell, WC; Elewksi, BE, 2014) |
| "To evaluate efficacy and cost of using cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs." | 5.10 | Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs. ( Hardie, RJ; McAnulty, JE; Patricelli, AJ, 2002) |
| "To determine the efficacy and toxicity of two systemically active antifungal agents in the treatment of buccal and oesophageal candidiasis 111 HIV-infected patients with microscopically-confirmed candidiasis were randomized to receive either 200 mg itraconazole once a day or 200 mg ketoconazole twice a day for 28 days in a double blind study." | 5.07 | Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. ( Allan, M; Connolly, GM; Gazzard, BG; Midgley, J; Smith, DE, 1991) |
| "Continuous prophylaxis with both-fluconazole and ketoconazole is effective in preventing recurrences of Candida esophagitis in AIDS patients; however, the possible emergence of strains resistant to these antifungals, as well as the high cost of the therapy, should raise doubts as to whether or not this type of prophylaxis should be extended to all AIDS patients with Candida esophagitis, rather than to limit its use to specific subgroups of patients, such as those with frequent symptomatic relapses." | 5.07 | Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study. ( Antinori, S; Ardizzone, S; Bianchi Porro, G; Cernuschi, M; Esposito, R; Lazzarin, A; Moroni, M; Parente, F, 1994) |
| "To assess the efficacy and safety of itraconazole in preventing relapse of histoplasmosis after induction therapy with amphotericin B in patients with the acquired immunodeficiency syndrome (AIDS) and disseminated histoplasmosis." | 5.07 | Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. ( Briggs, N; Connolly-Stringfield, P; Hafner, R; Hamill, R; Murphy, R; Owens, S; Powderly, W; Rinaldi, M; Saag, M; Spencer, P; Squires, K; Wheat, J; Wong, B; Wulfsohn, M, 1993) |
| "In a randomised, double-blind study the efficacy and toxicity of oral fluconazole 50 mg daily and ketoconazole 200 mg daily were compared for the treatment of oropharyngeal candidiasis in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC)." | 5.06 | Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. ( Clumeck, N; De Wit, S; Goossens, H; Weerts, D, 1989) |
| "Itraconazole, 200 to 400 mg once daily, was administered to 49 patients with different types of aspergillosis: pulmonary aspergilloma (14 patients), chronic necrotizing pulmonary aspergillosis (14), and invasive aspergillosis (21)." | 5.06 | Itraconazole therapy in aspergillosis: study in 49 patients. ( Dupont, B, 1990) |
| " One patient had 2 recurrent ischemic priapism episodes while on ketoconazole and prednisone treatment." | 3.75 | Ketoconazole and prednisone to prevent recurrent ischemic priapism. ( Abern, MR; Levine, LA, 2009) |
| " IN VITRO RESULTS: Fluconazole in a concentration of 500 microM nearly abolished corticosterone production over 24 h from the adrenal adenoma cell line Y-1 (8." | 3.73 | Long term control of hypercortisolism with fluconazole: case report and in vitro studies. ( Luger, A; Maier, C; Nowotny, P; Riedl, M; Schima, W; Zettinig, G, 2006) |
| "Relapse after apparently successful treatment of coccidioidomycosis has been a problem with both amphotericin B and the azoles." | 3.69 | Prediction of relapse after treatment of coccidioidomycosis. ( Bone, WD; Gray, GC; Martin, CR; Oldfield, EC; Olson, P; Schillaci, RF, 1997) |
| "Itraconazole, a new oral triazole antifungal agent, was administered in 75 courses to patients with chronic coccidioidomycosis at dosages of 50 to 400 mg/day for a median duration of 10 months." | 3.68 | Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations. ( Arathoon, EG; Denning, DW; Rinaldi, MG; Stevens, DA; Tucker, RM, 1990) |
| "The purpose of this study was to assess the tolerance and efficacy of itraconazole in the treatment of coccidioidomycosis." | 3.68 | Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group. ( Cloud, GA; Dismukes, WE; Galgiani, JN; Graybill, JR; Stevens, DA, 1990) |
| "Sixteen patients with coccidioidomycosis were treated with itraconazole for one year." | 3.68 | Itraconazole in the treatment of coccidioidomycosis. ( Cruz, S; de Hoyos, LA; Diaz, M; Puente, R, 1991) |
| "Ketoconazole appears to be a safe drug in the treatment of chronic cavitary histoplasmosis." | 3.67 | Chronic cavitary histoplasmosis. Failure of oral treatment with ketoconazole. ( Gorin, AB; Hamill, RJ; Musher, DM; Quinones, CA; Reuben, AG; Sarosi, GA, 1989) |
| " We examined four issues: the efficacy of treatment with amphotericin plus flucytosine as compared with amphotericin alone, the efficacy of suppressive therapy, the prognostic clinical characteristics, and the course of nonmeningeal cryptococcosis." | 3.67 | Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. ( Chuck, SL; Sande, MA, 1989) |
| "We report a patient with pulmonary blastomycosis who suffered relapse with dissemination of her disease after five months of apparent response to therapy with ketoconazole, 400 mg daily." | 3.67 | Late dissemination of pulmonary blastomycosis during ketoconazole therapy. ( George, RB; Hebert, CA; King, JW, 1989) |
| "Forty-seven courses of oral ketoconazole therapy administered to 46 patients with progressive coccidioidomycosis were evaluated." | 3.66 | Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis. ( Stevens, DA; Stiller, RL; Sugar, AM; Williams, PL, 1983) |
| "On further follow up, recurrence of onychomycosis was recorded in two patients in group I." | 2.73 | Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial. ( Bansal, S; Grover, C; Kumar, V; Nanda, S; Reddy, BS, 2007) |
| "Recurrence was not observed in any of the dogs that had bilateral surgical excision and or in 9 dogs that had unilateral excision." | 2.72 | Preoperative immunosuppressive therapy and surgery as a treatment for anal furunculosis. ( Deneuche, A; Desbois, C; Fayolle, P; Hidalgo, A; Klein, A; Moissonnier, P; Scotti, S; Tessier, D; Viateau, V; Zylberstein, L, 2006) |
| "Clinical recurrence of candida vaginitis with confirmation by smear and culture." | 2.67 | The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole. ( Fong, IW, 1992) |
| " In group 2, on 57 of 3316 days (2%), fluconazole in a higher dosage was administered for treatment." | 2.67 | Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. ( Gentschew, G; Helm, EB; Just-Nübling, G; Meissner, K; Odewald, J; Staszewski, S; Stille, W, 1991) |
| "Long-term safety and prevention of recurrence remain to be established." | 2.66 | Itraconazole therapy for recalcitrant dermatophyte infections. ( Hanifin, JM; Tofte, SJ, 1988) |
| "Cure and recurrence rates were not different in the three treatment groups, with or without simultaneous treatment of the male partner." | 2.66 | Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study. ( Bisschop, MP; Merkus, JM; Scheygrond, H; van Cutsem, J, 1986) |
| "The therapy of coccidioidomycosis has been an early target, both experimentally and clinically, for study of new members of the azole class of drugs, because of the recognition that coccidioidomycosis is one of the most difficult mycoses to treat, and because our research group and our collaborators have been eager to pioneer new therapies for this problem pathogen." | 2.44 | Azole therapy of clinical and experimental coccidioidomycosis. ( Clemons, KV; Stevens, DA, 2007) |
| "Cushing disease is most frequently caused by pituitary adenomas that secrete adrenocorticotrophic hormone." | 2.44 | Management of recurrent and refractory Cushing disease. ( Aghi, MK, 2008) |
| "Because many patients experience recurrences once prophylaxis is discontinued, long-term therapy may be warranted." | 2.41 | Treatment of recurrent vulvovaginal candidiasis. ( Ringdahl, EN, 2000) |
| "Blastomycosis is a rare but important fungal infection that is diagnosed primarily in the south-central and midwestern United States." | 2.40 | Therapy of blastomycosis. ( Bradsher, RW, 1997) |
| " The proper duration and dosage and the combination of antifungal drugs have not been clearly defined." | 2.38 | [Primary Aspergillus endocarditis. Apropos of a case and review of the international literature]. ( Cajot, MA; Gosselin, B; Goullard, L; Koussa, A; Marquette, F; Pol, A; Roux, JP; Soots, G; Warembourg, H, 1992) |
| "Almost all patients with prostatic cancer will eventually escape the control of the first-line endocrine therapy and relapse." | 2.38 | Management of relapsing disease in prostate cancer. ( Denis, L; Mahler, C, 1992) |
| "that may contribute to recurrence can be eliminated at the same time." | 2.38 | Chronic vulvovaginal candidosis: the role of oral treatment. ( Merkus, JM; Van Heusden, AM, 1990) |
| "Favus is common in Iran, Nigeria, and China, however it has been reported rarely in the last two decades in Turkey." | 1.42 | [A recurrent case of adult favus successfully treated with terbinafine]. ( Acar, A; Erkan, D; İlkit, M; Kandemir, H; Kolukırık, İ, 2015) |
| " We compared our previous protocol of three times daily (TID) KTZ dosing with prednisone for 6 months with our current regimen of initiating KTZ 200 mg TID with prednisone 5 mg daily for 2 weeks and then tapering to KTZ 200 mg nightly for 6 months." | 1.40 | Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes. ( Hoeh, MP; Levine, LA, 2014) |
| "Delayed hypopituitarism and endocrine recurrence develop in a minority of patients and underscore the need for long-term multidisciplinary follow-up." | 1.39 | Results of gamma knife surgery for Cushing's disease. ( Salvetti, DJ; Schmitt, PJ; Sheehan, JP; Vance, ML; Xu, Z, 2013) |
| "In the eumycetoma group, longer treatment duration (OR=1." | 1.38 | Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan. ( Abdel-Rahman, ME; El Hassan, TA; Fahal, AH; Mahgoub, el S; Zein, HA, 2012) |
| "Itching was frequent (70%)." | 1.34 | [Malassezia folliculitis: characteristics and therapeutic response in 26 patients]. ( Dubertret, L; Feuilhade de Chauvin, M; Flageul, B; Lévy, A; Morel, P, 2007) |
| "Chronic mucocutaneous candidiasis is a immuno deficiency disorder primarily due to T cell dysfunction characterized by persistent candidal infection of mucous membrane, skin, scalp and nails." | 1.32 | Chronic mucocutaneous candidiasis: a case report. ( Bhowate, R; Dubey, A, 2004) |
| "Ketoconazole was administered orally and adjusted according to individual response and 24-hour urinary free cortisol excretion levels." | 1.31 | Long-term effects of ketoconazole in the treatment of residual or recurrent Cushing's disease. ( Chou, SC; Lin, JD, 2000) |
| " glabrata was less susceptible (4-8 mg/l) or resistant (> 8 mg/l) to fluconazole and resistant to itraconazole and ketoconazole High dosed intravenous fluconazole treatment with 400 to 600 mg daily failed in 11 patients with fluconazole resistant C." | 1.30 | [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole]. ( Hofmann, H; Metzger, S, 1997) |
| "Treatment with ketoconazole and potassium iodide did not prevent several relapses." | 1.28 | Rhinofacial zygomycosis caused by Conidiobolus coronatus. A case report. ( Costa, AR; Cucé, LC; dos Reis, VM; Lacaz, Cda S; Müller, H; Pegas, JR; Pires, MC; Porto, E; Rodrigues, MC, 1991) |
| "Although there is no explanation for recurrence in most cases of CRCV, intermittent treatment schedules can be used to treat but not to cure these patients." | 1.28 | Chronic recurrent vaginal candidosis: easy to treat, difficult to cure. Results of intermittent treatment with a new oral antifungant. ( Merkus, JM; van Heusden, AM, 1990) |
| "Long-standing disseminated lesions of pityriasis versicolor (PV) were found in 101 patients." | 1.27 | Ketoconazole--an effective treatment for disseminated pityriasis versicolor. ( Kahana, M; Levy, A; Schewach-Millet, M; Shalish, L; Sommer, B; Yaron-Schiffer, O, 1984) |
| "Ketoconazole is an alternative when a replacement for griseofulvin is required, provided the degree of disability justifies the risk of drug toxicity." | 1.27 | Long-term ketoconazole treatment of chronic acral dermatophyte infections. ( Hersle, K; Mobacken, H; Moberg, S, 1985) |
| "A case of mycetoma of the lower leg (Madura foot) with bone involvement caused by Petriellidium boydii is presented." | 1.27 | [Mycetoma caused by Petriellidium boydii: treatment with ketoconazole]. ( Auböck, J; Fritsch, P; Pichler, E, 1985) |
| " Review of these five cases and 31 additional relapsing cases from the literature indicates that fungal endocarditis or endarteritis without surgical treatment, underlying lymphoreticular neoplasm, and amphotericin B dosage of less than 2 g appear to be associated with relapse of PDH." | 1.26 | Conditions associated with relapse of amphotericin B-treated disseminated histoplasmosis. ( Alford, RH; Bradsher, RW; Hawkins, SS; Spickard, WA, 1982) |
| "Ketoconazole is an affective therapeutic agent for griseofulvin-resistant dermatophytosis." | 1.26 | Ketoconazole in griseofulvin-resistant dermatophytosis. ( Hanifin, JM; Parker, F; Rich, P; Robertson, MH, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (34.86) | 18.7374 |
| 1990's | 43 (39.45) | 18.2507 |
| 2000's | 19 (17.43) | 29.6817 |
| 2010's | 8 (7.34) | 24.3611 |
| 2020's | 1 (0.92) | 2.80 |
| Authors | Studies |
|---|---|
| Joice, GA | 1 |
| Liu, JL | 1 |
| Burnett, AL | 1 |
| Helou, J | 1 |
| Obeid, G | 1 |
| Moutran, R | 1 |
| Maatouk, I | 1 |
| Sheehan, JP | 1 |
| Xu, Z | 1 |
| Salvetti, DJ | 1 |
| Schmitt, PJ | 1 |
| Vance, ML | 1 |
| Hoeh, MP | 1 |
| Levine, LA | 2 |
| Liu, T | 1 |
| Qian, G | 1 |
| Wang, XX | 1 |
| Zhang, YG | 1 |
| Cantrell, WC | 1 |
| Elewksi, BE | 1 |
| Erkan, D | 1 |
| Kolukırık, İ | 1 |
| Acar, A | 1 |
| Kandemir, H | 1 |
| İlkit, M | 1 |
| Eichenfield, LF | 1 |
| Friedlander, SF | 1 |
| Aghi, MK | 1 |
| Eghwrudjakpor, PO | 1 |
| Allison, AB | 1 |
| Abern, MR | 1 |
| Zein, HA | 1 |
| Fahal, AH | 1 |
| Mahgoub, el S | 1 |
| El Hassan, TA | 1 |
| Abdel-Rahman, ME | 1 |
| Marrazzo, J | 1 |
| Patricelli, AJ | 1 |
| Hardie, RJ | 1 |
| McAnulty, JE | 1 |
| Chien, RN | 1 |
| Sheen, IS | 1 |
| Liaw, YF | 1 |
| Harvey, BH | 1 |
| Oosthuizen, F | 1 |
| Brand, L | 1 |
| Wegener, G | 1 |
| Stein, DJ | 1 |
| Bhowate, R | 1 |
| Dubey, A | 1 |
| Nieman, LK | 1 |
| Ilias, I | 1 |
| Riedl, M | 1 |
| Maier, C | 1 |
| Zettinig, G | 1 |
| Nowotny, P | 1 |
| Schima, W | 1 |
| Luger, A | 1 |
| Ho, T | 1 |
| Vrabec, JT | 1 |
| Yoo, D | 1 |
| Coker, NJ | 1 |
| Klein, A | 1 |
| Deneuche, A | 1 |
| Fayolle, P | 1 |
| Hidalgo, A | 1 |
| Scotti, S | 1 |
| Zylberstein, L | 1 |
| Desbois, C | 1 |
| Tessier, D | 1 |
| Moissonnier, P | 1 |
| Viateau, V | 1 |
| Stevens, DA | 5 |
| Clemons, KV | 1 |
| Grover, C | 1 |
| Bansal, S | 1 |
| Nanda, S | 1 |
| Reddy, BS | 1 |
| Kumar, V | 1 |
| Lévy, A | 2 |
| Feuilhade de Chauvin, M | 1 |
| Dubertret, L | 1 |
| Morel, P | 1 |
| Flageul, B | 1 |
| Sobel, JD | 5 |
| Schewach-Millet, M | 1 |
| Kahana, M | 1 |
| Yaron-Schiffer, O | 1 |
| Sommer, B | 1 |
| Shalish, L | 1 |
| Giam, YC | 1 |
| Rajan, VS | 1 |
| Samelson, LE | 1 |
| Lerner, SA | 1 |
| Resnekov, L | 1 |
| Anagnostopoulos, C | 1 |
| Robertson, MH | 1 |
| Rich, P | 1 |
| Parker, F | 1 |
| Hanifin, JM | 2 |
| Bradsher, RW | 2 |
| Alford, RH | 1 |
| Hawkins, SS | 1 |
| Spickard, WA | 1 |
| Perfect, JR | 1 |
| Durack, DT | 1 |
| Hamilton, JD | 1 |
| Gallis, HA | 1 |
| Faergemann, J | 1 |
| Djärv, L | 1 |
| Restrepo, A | 2 |
| Gómez, I | 2 |
| Cano, LE | 2 |
| Arango, MD | 2 |
| Gutiérrez, F | 2 |
| Sanín, A | 2 |
| Robledo, MA | 2 |
| Stiller, RL | 1 |
| Williams, PL | 1 |
| Sugar, AM | 1 |
| Marks, HJ | 1 |
| Puolakka, J | 1 |
| Tuimala, R | 1 |
| Mosnier-Pudar, H | 1 |
| Thomopoulos, P | 1 |
| Bertagna, X | 1 |
| Fournier, C | 1 |
| Guiban, D | 1 |
| Luton, JP | 1 |
| Ejaz, AA | 1 |
| Zabaneh, RI | 1 |
| Tiwari, P | 1 |
| Nawab, ZM | 1 |
| Leehey, DJ | 1 |
| Ing, TS | 1 |
| Schmitt, C | 1 |
| Stein, G | 1 |
| Mummaw, N | 1 |
| Christensen, S | 1 |
| Meriwether, C | 1 |
| Ysmail-Dahlouk, M | 1 |
| Amar Khodja, A | 1 |
| Ysmail-Dahlouk, S | 1 |
| Ait Belkacem, F | 1 |
| Stengel, F | 1 |
| Robles-Soto, M | 1 |
| Galimberti, R | 1 |
| Suchil, P | 1 |
| Parente, F | 1 |
| Ardizzone, S | 1 |
| Cernuschi, M | 1 |
| Antinori, S | 1 |
| Esposito, R | 1 |
| Moroni, M | 1 |
| Lazzarin, A | 1 |
| Bianchi Porro, G | 1 |
| Serneels, RA | 1 |
| Marshall, GS | 1 |
| Wampler, J | 1 |
| Miller, D | 1 |
| Adams, G | 1 |
| Fong, IW | 3 |
| Bannatyne, RM | 1 |
| Wong, P | 1 |
| Wheat, J | 1 |
| Hafner, R | 1 |
| Wulfsohn, M | 1 |
| Spencer, P | 1 |
| Squires, K | 1 |
| Powderly, W | 1 |
| Wong, B | 1 |
| Rinaldi, M | 1 |
| Saag, M | 1 |
| Hamill, R | 1 |
| Murphy, R | 1 |
| Connolly-Stringfield, P | 1 |
| Briggs, N | 1 |
| Owens, S | 1 |
| Nozais, JP | 1 |
| Canel, MA | 1 |
| Datry, A | 1 |
| Danis, M | 1 |
| Oldfield, EC | 1 |
| Bone, WD | 1 |
| Martin, CR | 1 |
| Gray, GC | 1 |
| Olson, P | 1 |
| Schillaci, RF | 1 |
| Metzger, S | 1 |
| Hofmann, H | 1 |
| Burgaleta, C | 1 |
| Care, SB | 1 |
| Lacey, SH | 1 |
| Capone, D | 1 |
| Wanke, B | 1 |
| Monteiro, PC | 1 |
| Lazéra, MS | 1 |
| de Noronha Andrade, G | 1 |
| do Valle, AC | 1 |
| Moreno, AM | 1 |
| Londero, AT | 1 |
| Ringdahl, EN | 1 |
| Chou, SC | 1 |
| Lin, JD | 1 |
| Shihadeh, AS | 1 |
| Nawafleh, AN | 1 |
| Samaranayake, YH | 1 |
| Samaranayake, LP | 1 |
| Tsang, PC | 1 |
| Wong, KH | 1 |
| Yeung, KW | 1 |
| Roux, JP | 1 |
| Koussa, A | 1 |
| Cajot, MA | 1 |
| Marquette, F | 1 |
| Goullard, L | 1 |
| Gosselin, B | 1 |
| Pol, A | 1 |
| Warembourg, H | 1 |
| Soots, G | 1 |
| Mahler, C | 1 |
| Denis, L | 1 |
| Tinelli, M | 1 |
| Michelone, G | 1 |
| Cavanna, C | 1 |
| Diaz, M | 1 |
| Puente, R | 1 |
| de Hoyos, LA | 1 |
| Cruz, S | 1 |
| Smith, DE | 1 |
| Midgley, J | 1 |
| Allan, M | 1 |
| Connolly, GM | 1 |
| Gazzard, BG | 1 |
| Viviani, MA | 2 |
| Horsburgh, B | 1 |
| Hirst, LW | 1 |
| Carey, T | 1 |
| Whitby, RM | 1 |
| Nimmo, G | 1 |
| Stallard, K | 1 |
| Just-Nübling, G | 1 |
| Gentschew, G | 1 |
| Meissner, K | 1 |
| Odewald, J | 1 |
| Staszewski, S | 1 |
| Helm, EB | 1 |
| Stille, W | 1 |
| Sharma, JB | 1 |
| Buckshee, K | 1 |
| Gulati, N | 1 |
| Khanderia, U | 1 |
| Guerin, V | 1 |
| Barbaud, A | 1 |
| Duquenne, M | 1 |
| Contet-Audonneau, N | 1 |
| Amiot, F | 1 |
| Ortega, F | 1 |
| Hartemann, P | 1 |
| Borelli, D | 1 |
| Jacobs, PH | 1 |
| Nall, L | 1 |
| Costa, AR | 1 |
| Porto, E | 1 |
| Pegas, JR | 1 |
| dos Reis, VM | 1 |
| Pires, MC | 1 |
| Lacaz, Cda S | 1 |
| Rodrigues, MC | 1 |
| Müller, H | 1 |
| Cucé, LC | 1 |
| Merkus, JM | 3 |
| Van Heusden, AM | 2 |
| Walsøe, I | 1 |
| Stangerup, M | 1 |
| Svejgaard, E | 1 |
| Fletcher, SM | 1 |
| Prussin, AJ | 1 |
| Graybill, JR | 1 |
| Galgiani, JN | 1 |
| Dismukes, WE | 1 |
| Cloud, GA | 1 |
| Tucker, RM | 2 |
| Denning, DW | 2 |
| Arathoon, EG | 1 |
| Rinaldi, MG | 1 |
| Tortorano, AM | 1 |
| Pagano, A | 1 |
| Vigevani, GM | 1 |
| Gubertini, G | 1 |
| Cristina, S | 1 |
| Assaisso, ML | 1 |
| Suter, F | 1 |
| Farina, C | 1 |
| Minetti, B | 1 |
| Hanson, LH | 1 |
| Dupont, B | 1 |
| Kovacs, GT | 1 |
| Westcott, M | 1 |
| Rusden, J | 1 |
| Pariser, DM | 1 |
| Malekzadeh, M | 1 |
| Overturf, GD | 1 |
| Auerbach, SB | 1 |
| Wong, L | 1 |
| Hirsch, M | 1 |
| De Wit, S | 1 |
| Weerts, D | 1 |
| Goossens, H | 1 |
| Clumeck, N | 1 |
| Salem, HT | 1 |
| Salah, M | 1 |
| Farid, A | 1 |
| Sabra, AM | 1 |
| Makarem, MH | 1 |
| Chuck, SL | 1 |
| Sande, MA | 1 |
| Tofte, SJ | 1 |
| Kutzer, E | 1 |
| Oittner, R | 1 |
| Leodolter, S | 1 |
| Brammer, KW | 1 |
| Hebert, CA | 1 |
| King, JW | 1 |
| George, RB | 1 |
| Quinones, CA | 1 |
| Reuben, AG | 1 |
| Hamill, RJ | 1 |
| Musher, DM | 1 |
| Gorin, AB | 1 |
| Sarosi, GA | 1 |
| Zaias, N | 1 |
| Hersle, K | 1 |
| Mobacken, H | 1 |
| Moberg, S | 1 |
| Kauffman, CA | 1 |
| Terpenning, MS | 1 |
| Vargas, J | 1 |
| Recacoechea, M | 1 |
| Fournier, EC | 1 |
| Bisschop, MP | 1 |
| Scheygrond, H | 1 |
| van Cutsem, J | 1 |
| O'Connor, MI | 1 |
| Flynn, PM | 1 |
| Barrett, FF | 1 |
| Herrod, HG | 1 |
| Zlatkov, V | 1 |
| Karag'ozov, I | 1 |
| Weisman, IM | 1 |
| Moreno, AJ | 1 |
| Parker, AL | 1 |
| Sippo, WC | 1 |
| Liles, WJ | 1 |
| Ansari, RA | 1 |
| Hindson, DA | 1 |
| Stevens, DL | 1 |
| Kloss, JG | 1 |
| Eschenbach, DA | 1 |
| Hummel, D | 1 |
| Gravett, MG | 1 |
| Silva-Cruz, A | 1 |
| Duarte, V | 1 |
| Vartian, CV | 1 |
| Shlaes, DM | 1 |
| Padhye, AA | 1 |
| Ajello, L | 1 |
| Auböck, J | 1 |
| Pichler, E | 1 |
| Fritsch, P | 1 |
| Gustafson, PR | 1 |
| Henson, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Double-Blind Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot Study[NCT05142254] | Phase 2 | 64 participants (Actual) | Interventional | 2022-04-01 | Active, not recruiting | ||
| Effectiveness of 4% Boric Acid in Distilled Water Versus Clotrimazole Solution in Otomycosis Patients.[NCT04824261] | 100 participants (Anticipated) | Interventional | 2021-06-01 | Not yet recruiting | |||
| A Phase IIa Randomized, Active-controlled, Double-blind, Dose-escalation Study in Patients With Vulvovaginal Candidiasis to Evaluate Dose Response Relationship of Clinical Efficacy, Safety and Tolerability of Topically Administered ProF-001[NCT03115073] | Phase 2/Phase 3 | 84 participants (Actual) | Interventional | 2017-04-04 | Completed | ||
| Pilot Study to Determine the Feasibility of Itraconazole for Suppression of Relapse of Disseminated Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome[NCT00000992] | Phase 1 | 30 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for ketoconazole and Recrudescence
| Article | Year |
|---|---|
Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-Agonists; Algori | 2021 |
Pediatric Onychomycosis: The Emerging Role of Topical Therapy.
Topics: Administration, Topical; Adult; Age Factors; Antifungal Agents; Child; Ciclopirox; Family; Humans; I | 2017 |
Management of recurrent and refractory Cushing disease.
Topics: ACTH-Secreting Pituitary Adenoma; Adrenalectomy; Humans; Hypophysectomy; Ketoconazole; Models, Biolo | 2008 |
Vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Fe | 2002 |
Evaluation and treatment of Cushing's syndrome.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Adult; Antifungal Agents; Child; Cushing Syndrome; Diagn | 2005 |
Azole therapy of clinical and experimental coccidioidomycosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Azoles; Coccidioidomycosis; Disease Models, Animal | 2007 |
Therapy of blastomycosis.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Dose-Response Relationship, Drug; Humans; Itracona | 1997 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidia | 1995 |
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; | 2000 |
[Primary Aspergillus endocarditis. Apropos of a case and review of the international literature].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; | 1992 |
Management of relapsing disease in prostate cancer.
Topics: Aminoglutethimide; Androgen Antagonists; Antineoplastic Agents; Combined Modality Therapy; Estrogens | 1992 |
Cushing's disease and cutaneous alternariosis.
Topics: Aged; Alternaria; Cushing Syndrome; Dermatomycoses; Female; Humans; Immune Tolerance; Ketoconazole; | 1991 |
Tinea versicolor: epidemiologic, clinical, and therapeutic aspects.
Topics: Adult; Diagnosis, Differential; Female; Humans; Ketoconazole; Male; Recurrence; Terminology as Topic | 1991 |
Chronic vulvovaginal candidosis: the role of oral treatment.
Topics: Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Female; Humans; | 1990 |
Deep fungal infections in the elderly.
Topics: Age Factors; Aged; Amphotericin B; Blastomycosis; Coccidioidomycosis; Histoplasmosis; Humans; Ketoco | 1988 |
25 trials available for ketoconazole and Recrudescence
| Article | Year |
|---|---|
Can pityriasis versicolor be treated with 2% ketoconazole foam?
Topics: Administration, Cutaneous; Adult; Antifungal Agents; Female; Follow-Up Studies; Humans; Ketoconazole | 2014 |
Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs.
Topics: Administration, Oral; Animals; Cyclosporine; Dog Diseases; Dogs; Drug Interactions; Drug Therapy, Co | 2002 |
Preoperative immunosuppressive therapy and surgery as a treatment for anal furunculosis.
Topics: Anal Sacs; Animals; Anus Diseases; Combined Modality Therapy; Cyclosporine; Dog Diseases; Dogs; Fema | 2006 |
Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bandages; Child; Combined Modality Therapy; Drug Adminis | 2007 |
Oral Ketoconazole--a new treatment for Tinea Versicolor.
Topics: Administration, Oral; Adolescent; Adult; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Fe | 1984 |
Tinea versicolor: treatment and prophylaxis with ketoconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Follow-Up Studies; Humans; Imidazoles; Ketoconaz | 1982 |
Comparison between oral ketoconazole and topical miconazole in the treatment of vaginal candidiasis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Candidiasis, Vulvovaginal; Clinica | 1983 |
Initial management of recurrent vulvovaginal candidiasis with oral ketoconazole and topical clotrimazole.
Topics: Acute Disease; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Candidiasis, V | 1994 |
Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis.
Topics: Adult; Candida; Candidiasis, Cutaneous; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; | 1994 |
Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Esophagitis; Female; Fluconazole; Follow- | 1994 |
Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazol | 1993 |
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigen | 1993 |
The value of treating the male partner in vaginal candidiasis.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Chi-Square Distribution; Dose-Response Relat | 2000 |
The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Itraconazole; | 1992 |
The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Male; Recurren | 1992 |
Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Double-Blind Method; Esophageal Diseases; Female; | 1991 |
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Chronic Disease; Drug Administration Schedule | 1991 |
Itraconazole in onychomycosis. Open and double-blind studies.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Double-Blind Method; Female; Follow-Up Studies; H | 1990 |
Itraconazole therapy in aspergillosis: study in 49 patients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Enceph | 1990 |
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidi | 1989 |
Oral versus local treatment of vaginal candidosis.
Topics: Administration, Oral; Adolescent; Adult; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Mi | 1989 |
Itraconazole therapy for recalcitrant dermatophyte infections.
Topics: Adult; Clinical Trials as Topic; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Recu | 1988 |
A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Vulvovaginal; Clinica | 1988 |
Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Blind Method; Female; | 1986 |
Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Drug Administratio | 1986 |
69 other studies available for ketoconazole and Recrudescence
| Article | Year |
|---|---|
Pityriasis versicolor: a case of resistance to treatment.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconaz | 2014 |
Results of gamma knife surgery for Cushing's disease.
Topics: 14-alpha Demethylase Inhibitors; Female; Follow-Up Studies; Humans; Hypopituitarism; Ketoconazole; M | 2013 |
Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes.
Topics: 14-alpha Demethylase Inhibitors; Adolescent; Adult; Anemia, Sickle Cell; Clinical Protocols; Emergen | 2014 |
CHILD syndrome: effective treatment of ichthyosiform naevus with oral and topical ketoconazole.
Topics: 3-Hydroxysteroid Dehydrogenases; Abnormalities, Multiple; Administration, Cutaneous; Administration, | 2015 |
[A recurrent case of adult favus successfully treated with terbinafine].
Topics: Antifungal Agents; Drug Therapy, Combination; Female; Hair Follicle; Humans; Ketoconazole; Miconazol | 2015 |
Neurocryptococcosis in a 10-year-old immunocompetent girl.
Topics: Antifungal Agents; Biopsy, Fine-Needle; Brain; Brain Abscess; Child; Consciousness Disorders; Cranio | 2009 |
Ketoconazole and prednisone to prevent recurrent ischemic priapism.
Topics: Adult; Drug Dosage Calculations; Glucocorticoids; Humans; Ischemia; Ketoconazole; Male; Middle Aged; | 2009 |
Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amputation, Surgical; Antifungal Agents; Child; Child, P | 2012 |
Unintentional rechallenge resulting in a causative relationship between ketoconazole and acute liver injury.
Topics: Acute Disease; Antifungal Agents; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Female; Hu | 2003 |
Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus.
Topics: Animals; Chromatography, High Pressure Liquid; Corticosterone; Electrochemistry; Enzyme Inhibitors; | 2004 |
Chronic mucocutaneous candidiasis: a case report.
Topics: Antifungal Agents; Autoimmunity; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Child; Femal | 2004 |
Long term control of hypercortisolism with fluconazole: case report and in vitro studies.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aged, 80 and over; Antifungal Agents; Cell Line, Tu | 2006 |
Otomycosis: clinical features and treatment implications.
Topics: Acetates; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Ch | 2006 |
[Malassezia folliculitis: characteristics and therapeutic response in 26 patients].
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Dermato | 2007 |
Vulvovaginal candidiasis--what we do and do not know.
Topics: Candidiasis, Vulvovaginal; Chronic Disease; Female; Humans; Ketoconazole; Recurrence | 1984 |
Ketoconazole--an effective treatment for disseminated pityriasis versicolor.
Topics: Administration, Oral; Adolescent; Adult; Child; Female; Humans; Ketoconazole; Male; Middle Aged; Rec | 1984 |
Relapse of Candida parapsilosis endocarditis after long-term suppression with flucytosin: retreatment with valve replacement and ketoconazole.
Topics: Adult; Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Endocarditis; Female; Flucy | 1980 |
Ketoconazole in griseofulvin-resistant dermatophytosis.
Topics: Adult; Antifungal Agents; Chronic Disease; Dermatomycoses; Drug Resistance; Follow-Up Studies; Grise | 1982 |
Conditions associated with relapse of amphotericin B-treated disseminated histoplasmosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Endocarditis; Histoplasmosis; Humans; Imidazoles; Ketoconaz | 1982 |
Failure of ketoconazole in cryptococcal meningitis.
Topics: Antigens, Fungal; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Mic | 1982 |
Treatment of paracoccidioidomycosis with ketoconazole: a three-year experience.
Topics: Adult; Aged; Antifungal Agents; Drug Evaluation; Female; Humans; Imidazoles; Ketoconazole; Male; Mid | 1983 |
Post-therapy status of paracoccidioidomycosis treated with ketoconazole.
Topics: Antibodies, Fungal; Antifungal Agents; Follow-Up Studies; Humans; Imidazoles; Ketoconazole; Male; Pa | 1983 |
Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis.
Topics: Adult; Aged; Antifungal Agents; Bone Diseases; Coccidioidomycosis; Dermatomycoses; Drug Evaluation; | 1983 |
[Oral treatment of chronic recurring vaginal candidiasis with Nizoral].
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Drug Evaluation; F | 1983 |
Long-distance and long-term follow-up of a patient with intermittent Cushing's disease by salivary cortisol measurements.
Topics: Africa, Northern; Cushing Syndrome; Female; Humans; Hydrocarbons, Chlorinated; Hydrocortisone; Ketoc | 1995 |
Ketoconazole in the treatment of recurrent nephrolithiasis associated with sarcoidosis.
Topics: Adult; Humans; Hypercalcemia; Ketoconazole; Kidney Calculi; Lymphatic Diseases; Male; Recurrence; Sa | 1994 |
[Lupoid leishmaniasis].
Topics: Adolescent; Chronic Disease; Diagnosis, Differential; Facial Dermatoses; Female; Humans; Infant; Ket | 1994 |
Pulmonary sequestration with primary blastomycosis. Failure of ketoconazole therapy after resection.
Topics: Blastomycosis; Bronchopulmonary Sequestration; Child, Preschool; Female; Humans; Ketoconazole; Lung | 1993 |
[Mycetoma of the neck and the nape of the neck due to Madurella mycetomatis. Apropos of a case in Mauritania].
Topics: Adult; Antifungal Agents; Dermatomycoses; Humans; Itraconazole; Ketoconazole; Male; Mauritania; Mito | 1995 |
Prediction of relapse after treatment of coccidioidomycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Cohort Studies; Female; Fl | 1997 |
[Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Or | 1997 |
Recurrent histoplasmosis of the wrist: a case report.
Topics: Adult; Antifungal Agents; Carpal Tunnel Syndrome; Histoplasmosis; Humans; Itraconazole; Ketoconazole | 1998 |
Chronic pulmonary histoplasmosis in the State of Rio de Janeiro, Brazil.
Topics: Aged; Amphotericin B; Antifungal Agents; Brazil; Fatal Outcome; Female; Histoplasma; Histoplasmosis; | 1999 |
Long-term effects of ketoconazole in the treatment of residual or recurrent Cushing's disease.
Topics: Adult; Cushing Syndrome; Female; Follow-Up Studies; Humans; Hydrocortisone; Ketoconazole; Middle Age | 2000 |
Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agent | 2001 |
Recurrent Histoplasma capsulatum pneumonia: a case report.
Topics: Adult; Amphotericin B; Dust; Histoplasmosis; Humans; Ketoconazole; Male; Occupational Diseases; Pneu | 1992 |
Itraconazole in the treatment of coccidioidomycosis.
Topics: Adult; Antifungal Agents; Coccidioidomycosis; Female; Humans; Itraconazole; Ketoconazole; Lung Disea | 1991 |
[Mycoses as opportunistic infections in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; H | 1991 |
Steroid sensitive Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Cornea; Female; Humans; Ketoconazole; Predniso | 1991 |
Oral ketoconazole and miconazole vaginal pessary treatment for vaginal candidosis.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Drug Therapy, Combination; Female; Follow-Up | 1991 |
Use of ketoconazole in the treatment of Cushing's syndrome.
Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Cushing Syndrome; Humans; Ketoconazole; R | 1991 |
Rhinofacial zygomycosis caused by Conidiobolus coronatus. A case report.
Topics: Aged; Agricultural Workers' Diseases; Brazil; Edema; Face; Female; Fluconazole; Fungi; Humans; Ketoc | 1991 |
Histoplasmosis of the larynx treated with ketoconazole: a case report.
Topics: Chronic Disease; Histoplasmosis; Humans; Ketoconazole; Laryngeal Diseases; Laryngoscopy; Male; Middl | 1990 |
Chronic recurrent vaginal candidosis: easy to treat, difficult to cure. Results of intermittent treatment with a new oral antifungant.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Drug Adm | 1990 |
Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bone Diseases; Coccidioidomycosis; Dermatomycoses; Drug | 1990 |
Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chronic Disease; Coccidioides; Coccidioidomycosis; Drug | 1990 |
European experience with itraconazole in systemic mycoses.
Topics: Antifungal Agents; Aspergillosis; Child; Cryptococcosis; Drug Administration Schedule; Humans; Itrac | 1990 |
Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; | 1990 |
A prospective study to assess the efficacy of ketoconazole in the treatment of recurrent vaginal candidiasis.
Topics: Administration, Oral; Adolescent; Adult; Candidiasis, Vulvovaginal; Consumer Behavior; Female; Human | 1990 |
Tinea versicolor. A practical guide for primary care physicians.
Topics: Administration, Oral; Administration, Topical; Humans; Ketoconazole; Recurrence; Tinea Versicolor | 1990 |
Chronic, recurrent osteomyelitis caused by Scedosporium inflatum.
Topics: Child; Chronic Disease; Debridement; Drainage; Foot Diseases; Humans; Ketoconazole; Male; Mitosporic | 1990 |
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Cryptococcosis; Cryptococcus neofor | 1989 |
Late dissemination of pulmonary blastomycosis during ketoconazole therapy.
Topics: Adult; Blastomycosis; Dermatomycoses; Female; Humans; Ketoconazole; Lung; Lung Diseases, Fungal; Rad | 1989 |
Chronic cavitary histoplasmosis. Failure of oral treatment with ketoconazole.
Topics: Administration, Oral; Amphotericin B; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal; M | 1989 |
Onychomycosis.
Topics: Adult; Candida albicans; Candidiasis, Chronic Mucocutaneous; Foot Dermatoses; Glutaral; Griseofulvin | 1985 |
Long-term ketoconazole treatment of chronic acral dermatophyte infections.
Topics: Female; Griseofulvin; Hand Dermatoses; Humans; Ketoconazole; Male; Middle Aged; Onychomycosis; Recur | 1985 |
Ketoconazole in the treatment of paracoccidioidomycosis (South American blastomycosis). Experience in 30 cases in Bolivia.
Topics: Adult; Aged; Drug Evaluation; Female; Follow-Up Studies; Humans; Ketoconazole; Male; Middle Aged; Pa | 1988 |
Trial of ketoconazole in allergic bronchopulmonary aspergillosis.
Topics: Aspergillosis, Allergic Bronchopulmonary; Humans; Ketoconazole; Male; Recurrence | 1987 |
Epidemiology of recurrent vulvovaginal candidiasis: identification and strain differentiation of Candida albicans.
Topics: Candida albicans; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Male; Mouth; Penis; Rectu | 1986 |
Disseminated histoplasmosis in two patients with chronic mucocutaneous candidiasis.
Topics: Adult; Amphotericin B; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Female; Histoplasmosi | 1987 |
[Initial impressions from using the new oral antimycotic Nizoral].
Topics: Administration, Oral; Candidiasis, Vulvovaginal; Chronic Disease; Drug Evaluation; Female; Humans; K | 1987 |
Gastrointestinal dissemination of coccidioidomycosis.
Topics: Adult; Amphotericin B; Chylous Ascites; Coccidioidomycosis; Gastrointestinal Diseases; Humans; Ketoc | 1986 |
Pseudallescheria boydii arthritis and osteomyelitis in a patient with Cushing's disease.
Topics: Adrenalectomy; Arthritis, Infectious; Combined Modality Therapy; Cushing Syndrome; Humans; Ketoconaz | 1987 |
Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis.
Topics: Adult; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Male; Microbial Sensitivity Tests; M | 1985 |
Recurrent and persistent vulvovaginal candidiasis: treatment with ketoconazole.
Topics: Adult; Bacteriological Techniques; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Middle A | 1985 |
The management of genital candidosis with an oral antimycotic agent, ketoconazole.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Candidiasis, Vulvovaginal; Contracep | 1986 |
Wangiella dermatitidis endocarditis in an intravenous drug user.
Topics: Adult; Amphotericin B; Aortic Valve; Drug Therapy, Combination; Endocarditis; Heart Valve Diseases; | 1985 |
[Mycetoma caused by Petriellidium boydii: treatment with ketoconazole].
Topics: Adult; Amputation, Surgical; Foot Dermatoses; Humans; Ketoconazole; Male; Mycetoma; Pseudallescheria | 1985 |
Ketoconazole therapy for AIDS patients with disseminated histoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Histoplasmosis; Humans; Ketoconazole; Male; Recurrence | 1985 |